Allergan Inc. Chief Executive David Pyott is looking at potential sizable acquisitions, at the urging of his shareholders, he said on Wednesday, as he seeks to fight off a $53 billion hostile offer from Valeant Pharmaceuticals International Inc. and activist investor William Ackman.
Help employers find you! Check out all the jobs and post your resume.
